CSIMarket Company Name, Ticker, Suppliers, else..
 
Phio Pharmaceuticals Corp  (NASDAQ: PHIO)
 

Phio Pharmaceuticals's Suppliers Performance

PHIO's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
PHIO Costs vs Sales of Suppliers Growth

• More on PHIO Suppliers






Phio Pharmaceuticals's Comment on Supply Chain


The company contracts with multiple manufacturers to supply and produce its oligonucleotide product candidates to mitigate the risk of supply interruptions. The limited number of oligonucleotide manufacturers and supply chain constraints have resulted in delays and shortages. If current manufacturers are unable to supply or increase capacity, the company may need to identify alternative manufacturers, which could delay product development and regulatory approval. Manufacturing facilities are required to comply with FDA current Good Manufacturing Practice (cGMP) regulations; non-compliance may lead to enforcement actions and supply delays. Transitioning to new manufacturers necessitates verification of compliance, potentially causing additional delays and increased costs.

Phio Pharmaceuticals's Comment on Supply Chain


The company contracts with multiple manufacturers to supply and produce its oligonucleotide product candidates to mitigate the risk of supply interruptions. The limited number of oligonucleotide manufacturers and supply chain constraints have resulted in delays and shortages. If current manufacturers are unable to supply or increase capacity, the company may need to identify alternative manufacturers, which could delay product development and regulatory approval. Manufacturing facilities are required to comply with FDA current Good Manufacturing Practice (cGMP) regulations; non-compliance may lead to enforcement actions and supply delays. Transitioning to new manufacturers necessitates verification of compliance, potentially causing additional delays and increased costs.







PHIO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Phio Pharmaceuticals Corp 11.73 0.00 -12.90 6
SUBTOTAL 0.00 0.00 0.00 -


Sources: Phio Pharmaceuticals Corp's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Phio Pharmaceuticals Corp’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.